Lifeward (LFWD) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.91% |
| Dec 31, 2025 | -55.39% |
| Sep 30, 2025 | -62.37% |
| Jun 30, 2025 | -58.81% |
| Mar 31, 2025 | -54.56% |
| Dec 31, 2024 | -59.47% |
| Sep 30, 2024 | -34.54% |
| Jun 30, 2024 | -37.79% |
| Mar 31, 2024 | -36.06% |
| Dec 31, 2023 | -31.77% |
| Sep 30, 2023 | -31.50% |
| Jun 30, 2023 | -27.11% |
| Mar 31, 2023 | -25.43% |
| Dec 31, 2022 | -23.74% |
| Sep 30, 2022 | -18.71% |
| Jun 30, 2022 | 22.45% |
| Mar 31, 2022 | 23.42% |
| Dec 31, 2021 | 310.50% |
| Sep 30, 2021 | 453.89% |
| Jun 30, 2021 | 455.32% |
| Mar 31, 2021 | 427.55% |
| Dec 31, 2020 | 101.99% |
| Sep 30, 2020 | 18.94% |
| Jun 30, 2020 | -31.09% |
| Mar 31, 2020 | 536.64% |
| Dec 31, 2019 | 454.24% |
| Sep 30, 2019 | 370.35% |
| Jun 30, 2019 | 1,466.14% |
| Mar 31, 2019 | 237.09% |
| Dec 31, 2018 | -47.53% |
| Sep 30, 2018 | -489.63% |
| Jun 30, 2018 | -137.14% |
| Mar 31, 2018 | -144.85% |
| Dec 31, 2017 | -55.12% |
| Sep 30, 2017 | -71.50% |
| Jun 30, 2017 | -57.73% |
| Mar 31, 2017 | -79.00% |
| Dec 31, 2016 | -60.52% |
| Dec 31, 2015 | -52.30% |
| Dec 31, 2014 | 678.78% |